Cargando…

US NIH issues funding for SARS vaccine development

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140234/
http://dx.doi.org/10.2165/00151234-200504710-00036
_version_ 1783518948778573824
collection PubMed
description
format Online
Article
Text
id pubmed-7140234
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71402342020-04-08 US NIH issues funding for SARS vaccine development PharmacoEcon Outcomes News Media Release Springer International Publishing 2013-01-30 2005 /pmc/articles/PMC7140234/ http://dx.doi.org/10.2165/00151234-200504710-00036 Text en © Adis International Ltd 2005 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Media Release
US NIH issues funding for SARS vaccine development
title US NIH issues funding for SARS vaccine development
title_full US NIH issues funding for SARS vaccine development
title_fullStr US NIH issues funding for SARS vaccine development
title_full_unstemmed US NIH issues funding for SARS vaccine development
title_short US NIH issues funding for SARS vaccine development
title_sort us nih issues funding for sars vaccine development
topic Media Release
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140234/
http://dx.doi.org/10.2165/00151234-200504710-00036